Raythatha Jigar
Insider CIK 1745787 · CNST See Remarks, Director, 10% owner · JNCE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 31,400 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 20,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2022-06-24 | 2022-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2021-09-13 | 2021-09-15 | 31,400 | — | $0 | 31,400 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 141,929 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 423,940 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 141,929 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 204,500 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 245,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 306,938 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 200,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer | 2021-07-15 | 2021-07-19 | 14,961 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2021-02-16 | 2021-02-18 | 204,500 | — | $0 | 204,500 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | M Exercise deriv | 2020-05-12 | 2020-05-13 | 9,209 | — | $0 | 423,940 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | M Exercise | 2020-05-12 | 2020-05-13 | 9,209 | $5.51 | $50.7K | 24,170 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | S Sale | 2020-05-12 | 2020-05-13 | 9,209 | $50.17 | $462.0K | 14,961 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | M Exercise deriv | 2020-05-11 | 2020-05-13 | 26 | — | $0 | 433,149 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | M Exercise | 2020-05-11 | 2020-05-13 | 26 | $5.51 | $143 | 14,987 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | S Sale | 2020-05-11 | 2020-05-13 | 26 | $50.00 | $1.3K | 14,961 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2020-02-14 | 2020-02-18 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | M Exercise deriv | 2019-11-06 | 2019-11-08 | 102,750 | — | $0 | 433,175 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | S Sale | 2019-11-06 | 2019-11-08 | 3,170 | $21.20 | $67.2K | 97,161 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | M Exercise | 2019-11-06 | 2019-11-08 | 102,750 | $5.51 | $566.2K | 117,711 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | S Sale | 2019-11-06 | 2019-11-08 | 20,200 | $35.23 | $711.6K | 15,311 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | S Sale | 2019-11-06 | 2019-11-08 | 350 | $36.01 | $12.6K | 14,961 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | S Sale | 2019-11-06 | 2019-11-08 | 20,550 | $25.06 | $515.0K | 76,611 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | S Sale | 2019-11-06 | 2019-11-08 | 29,005 | $30.19 | $875.7K | 47,606 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | S Sale | 2019-11-06 | 2019-11-08 | 12,095 | $31.32 | $378.8K | 35,511 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | S Sale | 2019-11-06 | 2019-11-08 | 17,380 | $20.18 | $350.7K | 100,331 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2019-03-07 | 2019-03-08 | 245,000 | — | $0 | 245,000 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2018-07-19 | 2018-07-20 | 306,938 | — | $0 | 306,938 | SEC↗ |